Smartlab Europe

Marck to introduce Paracetamol IV in plastic package in India

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Sustainable Nutraceutical Ingredients Shaping the Future

The Shift Toward Sustainable Ingredients One of the most significant...

SGD Pharma Advances Nasal Drug Delivery with Prince Deal

SGD Pharma has entered into a Franco-American OEM collaboration...

Managing PFAS Regulations in Pharmaceutical Supply Chains

PFAS regulations in pharmaceutical supply chains are reshaping how critical materials are sourced, validated, and justified amid rising environmental scrutiny. Manufacturers must balance sustainability, regulatory compliance, and material performance to ensure uninterrupted delivery of safe and effective medicines.
- Advertisement -

Marck Biosciences is set to introduce Paracetamol IV in plastic package, which is manufactured by using Blow-Fill-Seal (BFS) technology, under Febramol IV brand name in India.
The company already exports the drug to West Africa, South East Asia and Middle East markets.Marck has obtained approvals for the product in Benin, Kenya, Yemen, Nigeria, Mali and Vietnam and is due to register it in CIS countries, East Africa and Latin American countries.

Marck MD Bhavesh Patel said they are focussing on a two- pronged strategy of marketing Paracetamol IV under their own brand name and contract manufacturing to grow exponentially in the coming year.

Latest stories

Related stories

Sustainable Nutraceutical Ingredients Shaping the Future

The Shift Toward Sustainable Ingredients One of the most significant...

SGD Pharma Advances Nasal Drug Delivery with Prince Deal

SGD Pharma has entered into a Franco-American OEM collaboration...

Managing PFAS Regulations in Pharmaceutical Supply Chains

PFAS regulations in pharmaceutical supply chains are reshaping how critical materials are sourced, validated, and justified amid rising environmental scrutiny. Manufacturers must balance sustainability, regulatory compliance, and material performance to ensure uninterrupted delivery of safe and effective medicines.

Leveraging Global Drug Databases to Accelerate Research and Development

Accessing comprehensive global drug databases streamlines the drug development process, allowing researchers to utilize existing clinical data and regulatory benchmarks to shorten innovation cycles.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »